文献速递肝病

中国人群NAFLD相关基因多态性与全因及病因特异性死亡:上海长风研究

NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-01-12

在上海长风研究的5581名中国成人中,PNPLA3 rs738409 C>G变异与肝脏特异性死亡升高相关(趋势P=0.034),但与心血管死亡降低相关(趋势P=0.047);PNPLA3、TM6SF2和MBOAT7风险等位基因复合评分呈现相似的反向效应,且与肥胖存在交互作用(交互P<0.05)。

要点

  • PNPLA3 rs738409 C>G独立关联肝脏特异性死亡升高(趋势P=0.034)与心血管死亡降低(趋势P=0.047)。
  • PNPLA3、TM6SF2、MBOAT7风险等位基因复合评分对肝脏与心血管死亡呈相似反向效应。
  • NAFLD风险等位基因与肥胖对肝脏特异性死亡存在交互作用(交互P<0.05)。

核心结论

  • PNPLA3 rs738409 C>G变异及其与TM6SF2 rs58542926 C>T、MBOAT7 rs641738 C>T变异的组合增加超重/肥胖中国人的肝脏特异性死亡但降低心血管死亡。

研究设计与样本

  • 研究纳入5581名中国成人,采用基因分型芯片检测全基因组基因型,用1H NMR平台检测血清脂蛋白谱,用定量超声法测量肝脏脂肪含量,并通过官方登记数据确定生命状态。

主要发现

  • 全基因组关联分析显示PNPLA3一系列变异与肝脏脂肪含量相关,包括rs738409 C>G变异(P=8.6×10-7)。
  • 进一步分析验证了TM6SF2 rs58542926 C>T和MBOAT7 rs641738 C>T变异与NAFLD的关联。
  • 随访29425.1人年期间,总死亡率为816/10万人年,其中299例死亡归因于心血管疾病、85例归因于肝脏疾病。
  • PNPLA3 rs738409 C>G变异独立关联肝脏特异性死亡升高(趋势P=0.034)但心血管死亡降低(趋势P=0.047)。
  • PNPLA3、TM6SF2和MBOAT7风险等位基因复合评分对肝脏特异性死亡和心血管死亡呈现相似的反向效应,且NAFLD风险等位基因与肥胖对肝脏特异性死亡存在交互作用(交互P<0.05)。

关键数值与推荐

  • PNPLA3 rs738409 C>G与肝脏脂肪含量相关(P=8.6×10-7)。
  • PNPLA3 rs738409 C>G与肝脏特异性死亡升高相关(趋势P=0.034),与心血管死亡降低相关(趋势P=0.047)。
  • NAFLD风险等位基因与肥胖对肝脏特异性死亡的交互作用P<0.05。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The PNPLA3 and TM6SF2 gene variants have been found to cause NAFLD with a favourable cardiovascular risk profile. AIMS: To investigate the effects of the NAFLD risk alleles on the all-cause and cause-specific mortality in 5581 Chinese adults. METHODS: The genome-wide genotypes were detected using a genotyping array and serum lipoprotein profiles were examined using 1H NMR platform. Liver fat content (LFC) was measured using a quantitative ultrasound method. The vital status was determined using official registration data. RESULTS: Genome-wide association analysis showed that a series of variants in PNPLA3 were associated with LFC, including rs738409 C>G variant (P = 8.6 × 10-7 ). Further analyses validated the associations of TM6SF2 rs58542926 C>T and MBOAT7 rs641738 C>T variants with NAFLD. During 29 425.1 person-years of follow-up, the overall mortality was 816 per 100 000 person-years, where 299 deaths were attributable to cardiovascular disease and 85 to liver disease. The PNPLA3 rs738409 C>G variant was independently associated with increased liver-specific mortality (P for trend = 0.034) but reduced cardiovascular mortality (P for trend = 0.047). A composite genetic-predisposition score of PNPLA3, TM6SF2, and MBOAT7 risk alleles presented similar opposite effects on liver-specific and cardiovascular mortality. Moreover, interactions of the NAFLD risk alleles with adiposity for liver-specific mortality were found (Pinteraction < 0.05). The reduced serum VLDL1 concentration was responsible for the increased liver-specific mortality related to NAFLD risk alleles. CONCLUSION: The PNPLA3 rs738409 C>G variant and its combination with TM6SF2 rs58542926 C>T and MBOAT7 rs641738 C>T variants increase liver-specific mortality but reduce cardiovascular mortality in overweight/obese Chinese.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Xia M, Ma S, Huang Q, et al. NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study. Aliment Pharmacol Ther. 2022. PMID: 35023183. doi:10.1111/apt.16772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。